ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 152 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $851,000 | +11.5% | 236,634 | +141.7% | 0.04% | +25.0% |
| Q2 2016 | $763,000 | +77.4% | 97,900 | +145.4% | 0.04% | +38.5% |
| Q4 2015 | $430,000 | +200.7% | 39,900 | +92.8% | 0.03% | +136.4% |
| Q3 2015 | $143,000 | -25.5% | 20,700 | +6.2% | 0.01% | -38.9% |
| Q1 2015 | $192,000 | -69.6% | 19,500 | -69.2% | 0.02% | -85.2% |
| Q3 2014 | $631,000 | -2.0% | 63,300 | -25.6% | 0.12% | +6.1% |
| Q2 2014 | $644,000 | – | 85,100 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |